Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  420 results for ""APOLIPOPROTEIN C""

Your Filters

Publisher : oxford university press / usa
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Exploring apolipoprotein C-III: pathophysiological and pharmacological relevance.

Subjects: APOLIPOPROTEIN C; LIPOPROTEIN lipase; BLOOD lipids

  • Source: Cardiovascular Research; Dec2023, Vol. 119 Issue 18, p2843-2857, 15p

Record details

Read More Add to Saved list
×
Academic Journal

Inverse association between apolipoprotein C-II and cardiovascular mortality: role of lipoprotein lipase activity modulation.

Subjects: LIPOPROTEIN lipase; APOLIPOPROTEIN C; CARRIER proteins

  • Source: European Heart Journal; 7/1/2023, Vol. 44 Issue 25, p2335-2345, 11p

Record details

Read More Add to Saved list
×
Academic Journal

Advances in nucleic acid-targeted therapies for cardiovascular disease prevention.

Subjects: *APOLIPOPROTEIN C; *SMALL interfering RNA; *LIPOPROTEIN receptors

  • Source: Cardiovascular Research. Jul2024, Vol. 120 Issue 10, p1107-1125. 19p.

Record details

Read More Add to Saved list
×
Academic Journal

Apolipoprotein C-II: a new look at an old protein.

Subjects: APOLIPOPROTEIN C; APOLIPOPROTEIN E4; CHYLOMICRONS

  • Source: European Heart Journal; 7/1/2023, Vol. 44 Issue 25, p2345-2347, 3p

Record details

Read More Add to Saved list
×
Academic Journal

Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk.

Subjects: APOLIPOPROTEIN C; CARDIOVASCULAR diseases risk factors; HYPERTRIGLYCERIDEMIA

  • Source: European Heart Journal; 4/7/2022, Vol. 43 Issue 14, p1401-1412, 12p

Record details

Read More Add to Saved list
×
Academic Journal

Drug-target Mendelian randomization analysis supports lowering plasma ANGPTL3, ANGPTL4, and APOC3 levels as strategies for reducing cardiovascular disease risk.

Subjects: APOLIPOPROTEIN C; CARDIOVASCULAR diseases; CARDIOVASCULAR diseases risk factors

  • Source: European Heart Journal Open; May2024, Vol. 4 Issue 3, p1-18, 18p

Record details

Read More Add to Saved list
×
Academic Journal

Nutrigenetic Interaction Between Apolipoprotein C3 Polymorphism and Fat Intake in People with Nonalcoholic Fatty Liver Disease.

Subjects: *NON-alcoholic fatty liver disease; *APOLIPOPROTEIN C; *FATJAPAN

  • Source: Current Developments in Nutrition. Apr2023, Vol. 7 Issue 4, p1-11. 11p.

Record details

Read More Add to Saved list
×
Academic Journal

Apolipoprotein C-III inhibition to lower triglycerides: one ring to rule them all?

Subjects: APOLIPOPROTEIN C; CHYLOMICRONS; LIPOPROTEINS

  • Source: European Heart Journal; 4/7/2022, Vol. 43 Issue 14, p1413-1415, 3p

Record details

Read More Add to Saved list
×
Academic Journal

Disconnect between triglyceride reduction and cardiovascular outcomes: lessons from the PROMINENT and CLEAR Outcomes trials.

Subjects: DYSLIPIDEMIA; LIPOPROTEIN lipase; CHOLESTERYL ester transfer protein

  • Source: European Heart Journal; 7/14/2024, Vol. 45 Issue 27, p2377-2379, 3p

Record details

Read More Add to Saved list
×
Academic Journal

dawn of a new era of targeted lipid-lowering therapies.

Subjects: ANGIOPOIETIN-like proteins; APOLIPOPROTEIN C; DISEASE risk factors

  • Source: European Heart Journal; 9/7/2022, Vol. 43 Issue 34, p3198-3208, 11p

Record details

Read More Add to Saved list
×
  • 1-10 of  420 results for ""APOLIPOPROTEIN C""